In Good Company (I Gott Sällskap)
Phenylketonuria (PKU) & related metabolic disorders
Commercial Support ProgramActive
Key Facts
Indication
Phenylketonuria (PKU) & related metabolic disorders
Phase
Commercial Support Program
Status
Active
Company
About Navamedic
Navamedic ASA is a publicly traded, commercial-stage Nordic pharmaceutical company generating significant revenue through the marketing and distribution of approved products. Its core business model involves in-licensing, marketing, and supplying pharmaceuticals and medical nutrition, with a particular focus on areas like Parkinson's disease and inherited metabolic disorders such as PKU. The company reported 2025 revenue of MNOK 565.4 and employs approximately 45 people. Its strategy combines portfolio growth with patient support initiatives to strengthen its position in the Nordic healthcare market.
View full company profile